Synovial sarcoma is characterised by a pathognomonic translocation between chromosome X and 18 (X:18), which results in the expression of fusion proteins including SS18-SSX1, SS18-SSX2, and SS18-SSX4 [5,6,7]. Here, SSX1 is linked to synovial sarcoma.